homeostasis, but excessive CaMKII activity contributes to abnormal Ca 2+ homeostasis and arrhythmias in cardiomyocytes. Reactive oxygen species induce CaMKII to become autonomously active. We hypothesized that genetic inhibition of CaMKII oxidation (ox-CaMKII) in a mouse model of Duchenne muscular dystrophy can alleviate abnormal Ca 2+ homeostasis, thus, preventing ventricular arrhythmia. The objective of this study was to test if selective loss of ox-CaMKII affects ventricular arrhythmias in the mdx mouse model of Duchenne muscular dystrophy.
METHODS AND RESULTS:
5-(6)-Chloromethyl-2,7-dichlorodihydrofluorescein diacetate staining revealed increased reactive oxygen species production in ventricular myocytes isolated from mdx mice, which coincides with elevated ventricular ox-CaMKII demonstrated by Western blotting. Genetic inhibition of ox-CaMKII by knockin replacement of the regulatory domain methionines with valines (MM-VV [CaMKII M281/282V]) prevented ventricular tachycardia in mdx mice. Confocal calcium imaging of ventricular myocytes isolated from mdx:MM-VV mice revealed normalization of intracellular Ca 2+ release events compared with cardiomyocytes from mdx mice. Abnormal action potentials assessed by optical mapping in mdx mice were also alleviated by genetic inhibition of ox-CaMKII. Knockout of the NADPH oxidase regulatory subunit p47 phox normalized elevated ox-CaMKII, repaired intracellular Ca 2+ homeostasis, and rescued inducible ventricular arrhythmias in mdx mice.
CONCLUSIONS:
Inhibition of reactive oxygen species or ox-CaMKII protects against proarrhythmic intracellular Ca 2+ handling and prevents ventricular arrhythmia in a mouse model of Duchenne muscular dystrophy. 1 DMD is a fatal disease, affecting 1 in 3500 male births, characterized by degeneration of muscle tissue with no definitive treatment. Patients with DMD often have cardiomyopathy and may develop cardiac arrhythmias. Cardiomyopathy is found in 25% of DMD patients under the age of 6 years, 59% of 10-year-old patients, and virtually all adult DMD patients. Moreover, 26% of DMD patients also exhibit ventricular tachycardia (VT) and 51% exhibit an increased heart rate variability. 2 Recent studies suggest that increased production of reactive oxygen species (ROS) may contribute to the development of cardiomyopathy in DMD. Studies in mdx mice, a mouse model of DMD, revealed enhanced ROS production in the hearts of these mice. 3, 4 Abnormal ROS production is one of the key factors leading to altered excitation-contraction coupling in mdx mice, which may contribute to contractile dysfunction and enhanced arrhythmogenesis. 4, 5 ROS can alter cardiac excitation-contraction coupling
WHAT IS KNOWN?
• Patients with Duchenne's muscular dystrophy develop life-threatening ventricular arrhythmias.
• Enhanced CaMKII (Ca 2+ /calmodulin-dependent protein kinase II) activity is associated with heart disease and arrhythmias and can be activated by multiple mechanisms including reactive oxygen species-mediated CaMKII oxidation.
WHAT THE STUDY ADDS?
• NADPH oxidase type 2-mediated reactive oxygen species-induced CaMKII activation in the mdx mouse model of Duchenne muscular dystrophy promotes aberrant Ca 2+ release and triggers ventricular arrhythmias.
• Genetic inhibition of NADPH oxidase type 2 reactive oxygen species production or CaMKII oxidation or pharmacological inhibition of CaMKII activity prevents ventricular arrhythmias in the mdx mice.
• Targeting CaMKII oxidation may be an effective strategy for treatment of ventricular arrhythmias in Duchenne muscular dystrophy.
through oxidation of various phosphatases and kinases, including CaMKII (Ca 2+ /calmodulin-dependent protein kinase II). 6, 7 CaMKII is a serine/threonine kinase essential for intracellular Ca 2+ homeostasis in cardiomyocytes. CaMKII activity is modulated by several posttranslational modifications, including autophosphorylation and oxidation, and aberrant CaMKII regulation contributes to development of heart failure and arrhythmias. 8, 9 Moreover, our studies have revealed that CaMKII-mediated phosphorylation of RyR2 promotes VT in mdx mice. 10 Oxidation of 2 methionine residues (M281 and M282) within the CaMKII regulatory domain locks CaMKII into a constitutively active, Ca 2+ -and calmodulin-independent conformational state. 7 Previous studies suggest that oxidized CaMKII (ox-CaMKII) can cause sinus node dysfunction. 11 Ox-CaMKII levels were found to be significantly increased in pacemaker tissues from diabetic patients compared with nondiabetic patients after myocardial infarction. Moreover, activation of a mitochondrial/ox-CaMKII pathway contributes to increased sudden death in diabetic patients after myocardial infarction. 12 In this study, we tested the hypothesis that increased ROS production promotes ventricular arrhythmias in a mouse model of DMD as a result of CaMKII oxidation. Our findings revealed increased oxidation of M281/ M282 on CaMKII in mdx mice. Genetic inhibition of oxidation of these residues prevented VT induction in mdx mice. We found that ox-CaMKII promoted spontaneous sarcoplasmic reticulum (SR) Ca 2+ release events and Ca 2+ waves that can lead to ectopic activity in the hearts of mdx mice. Finally, genetic ablation of p47 phox , a regulatory subunit of NADPH oxidase type 2 (NOX2), prevented CaMKII oxidation and VT, suggesting that NOX2 is involved in pathological ROS production in mdx mice.
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Experimental Animals
Mdx mice were obtained from Jackson Laboratories (C57BL/10ScSn-Dmdmdx/J). MM-VV (CaMKII M281/282V) mice, in which methionine residues 281 and 282 are substituted by valines and thereby cannot undergo oxidation, were previously reported. 
Mouse Ventricular Myocyte Isolation
Mouse ventricular myocytes were isolated as described. 4 Briefly, mice were anesthetized and hearts were removed into 0 Ca 2+ Tyrode solution (137 mmol/L NaCl, 5.4 mmol/L KCl, 1 mmol/L MgCl 2 , 5 mmol/L HEPES, 10 mmol/L glucose, 3 mmol/L NaOH, pH 7.4). The heart was cannulated through the aorta and connected to a Langendorff system, perfused with 0 Ca 2+ Tyrode for 5 minutes, followed by 0 Ca 2+ Tyrode containing 20 μg/mL Liberase (Roche, Indianapolis, IN) for 10 to 15 minutes at 37°C. After digestion, the heart was removed in Krebs-bicarbonate buffer (90 mmol/L KCl, 30 mmol/L K 2 HPO 4 , 5 mmol/L MgSO 4 , 5 mmol/L pyruvic acid, 5 mmol/L β-hydroxybutyric acid, 5 mmol/L creatine, 20 mmol/L taurine, 10 mmol/L glucose, 0.5 mmol/L EGTA, 5 mmol/L HEPES, pH 7.2). The digested heart was minced and agitated in Krebs-bicarbonate buffer, then filtered through a 210 mm polyethylene mesh. The isolated ventricular myocytes were kept in Krebsbicarbonate buffer before use.
Confocal Imaging
Confocal imaging was performed as described. 4, 13 Isolated ventricular myocytes were incubated in 2 mmol/L Fluo-4-acetoxymethyl ester (Fluo-4 am; Invitrogen, Carlsbad, CA) in normal Tyrode's solution containing 1.8 mmol/L Ca 2+ for 1 hour at room temperature, followed by 15 minutes for de-esterification with dye-free normal Tyrode's and loaded on a laser scanning confocal microscope (LSM 510; Carl Zeiss, Thornwood, NY). Fluorescence images were recorded in line-scan mode with 1024 pixels per line at 500 Hz. After myocytes reached steady state with pacing at 1 Hz, pacing was stopping, and Ca 2+ sparks were counted. Caffeine (10 mmol/L) was used to induce caffeine-induced Ca 2+ transient to calculate SR Ca 2+ content.
Western Blotting
Heart lysates were prepared from flash-frozen mouse ventricles as described. 14 Ox-CaMKII was detected by using an antibody specific for oxidized M281/M282 on CaMKII, developed by Dr Anderson (1:1000). 7, 10 Refer to Methods in the Data Supplement for further details.
CaMKII Activity Assay
Total CaMKII and Ca 2+ /CaM-independent CaMKII activity from mouse ventricular lysate were assessed using the SignaTECT CaMKII activity kit (Promega) in conjunction with γ-32P radiolabeled ATP (Perkin Elmer) according to the manufacturer's instructions as described. 15 See Methods in the Data Supplement for details.
Programmed Electric Stimulation
Atrial and ventricular intracardiac electrograms were recorded using a 1.1-F octapolar electrode catheter (EPR-800; Millar Instruments, Houston, TX) inserted into the right ventricle via the right jugular vein, as described. 16 VT inducibility was determined using a combination of overdrive pacing and single, double, and triple extrastimuli pacing protocols. Sustained VT was defined as ≥6 beats of VT.
Optical Mapping
After euthanasia, the mouse heart was quickly removed and rinsed in oxygenated (95% O 2 , 5% CO 2 ) cold normal Tyrode's solution containing 2.5 mmol/L Ca 2+ and 250 nmol/L isoproterenol. A pacing electrode (Harvard Apparatus, MA) was placed on the surface of the heart, connected to a stimulator (PowerLab 26T, AD Instruments, Sydney, Australia). The anterior epicardial surface was excited using an LED light source centered at 530 nm and band pass-filtered from 511 to 551 nm (LEX-2; SciMedia, CA). Blebbistatin (Sigma-Aldrich; B0560-5 mg, 50 μL of 2.5 mg/mL in dimethyl sulfoxide) was added to eliminate motion artifacts. The voltage-sensitive dye RH237 was added to the perfusate (Invitrogen, S-1109, 20 μL of 2.5 mg/mL in dimethyl sulfoxide). The emitted fluorescence Vm signal was collected through a 50 mm lens camera (Leica Plan APO 1.0×; SciMedia) and filtered at 700 nm. The right atrium was paced at 10 Hz (S1) followed by a single extrastimulus (S2) after 70 to 40 ms, decreasing by 2 ms every time.
Statistical Analysis
Results are expressed as mean±SEM. Continuous variables were evaluated using SPSS or Prism using an unpaired Student's t test or analysis of variance, after performing the D'Agostino-Pearson normality test for normal distribution of the data. Categorical variables were evaluated with Fisher exact test. P<0.05 was considered statistically significant.
RESULTS

Elevated Ox-CaMKII Increases Autonomously Activated CaMKII in mdx Mice
In recent studies, we demonstrated enhanced ROS production in the hearts of 3-month-old mdx mice. 4 Consistent with these findings, we found enhanced production of ROS by quantifying 5-(6)-chloromethyl-2,7-dichlorodihydrofluorescein diacetate fluorescence in ventricular myocytes of 5-month-old mdx mice compared with wild-type (WT) littermates ( Figure I in the Data Supplement). Western blotting revealed unaltered protein levels of CaMKII in the ventricles of mdx mice compared with WT littermates ( Figure 1A ). We previously demonstrated unaltered CaMKII autophosphorylation levels of CaM-KII in 5-month-old mdx mice. 10 In contrast, ox-CaMKII increased by 39±6% in mdx mice compared with WT controls (P<0.001; Figure 1B ). This enhanced CaMKII oxidation was abrogated by genetic inhibition of CaMKII oxidation in mdx:MM-VV mice, in which M281 and M282 on CaMKII are mutated to valine (MM-VV) to selectively ablate activation by oxidation, 12 while maintaining other pathways for activation including autophosphorylation ( Figure 1B) . Previously, it has been shown that CaMKII oxidation at M281/M282 can cause constitutive activation of CaMKII independent of Ca 2+ /CaM activation. 15 To determine whether this increase in ox-CaMKII indeed enhanced Ca 2+ /CaM-independent activation of CaMKII, we performed a CaMKII activity assay. Consistent with the finding that total CaMKII protein was unaltered, we found that total Ca 2+ /CaM-activatable CaMKII activity was not changed between groups ( Figure 1C, upper  panel) . Conversely, the Ca 2+ /CaM-independent activity was significantly increased 1.8-fold in mdx hearts compared with WT (P=0.037) and was ameliorated in mdx-MMVV hearts ( Figure 1C , lower panel; P=0.037). These findings suggest that CaMKII activity is increased in the hearts of mdx mice because of enhanced ROSmediated oxidation of M281/M282. 
Genetic Inhibition of Ox-CaMKII Prevents Ventricular Arrhythmia in mdx Mice
We previously demonstrated that mdx mice develop VT in response to programmed electric stimulation. Moreover, pharmacological and genetic inhibition of CaM-KII prevented VT induction in mdx mice. 10 To assess whether oxidation of CaMKII underlies the enhanced susceptibility to arrhythmias, we performed arrhythmia induction studies in mdx:MM-VV mice. While 50% of mdx mice developed reproducible sustained VT after intracardiac stimulation, none of the mdx:MM-VV mice developed VT (P<0.05; Figure 2 ). These results suggest that oxidation of CaMKII underlies susceptibility to ventricular arrhythmias in mdx mice. Figure 3C ). Genetic inhibition of ox-CaMKII significantly reduced the spark amplitude in mdx:MM-VV mice (0.31±0.004; P<0.001 versus mdx). Again, a similar reduction in spark amplitude was found in mdx cardiomyocytes treated with KN-93 (0.23±0.003; P<0.001).
Inhibition of Ox-CaMKII Normalizes
To further examine the potential proarrhythmic potential of aberrant SR Ca 2+ release event, ventricular myocytes were first subjected to a low-frequency pacing train (1-Hz) followed by a pause. There was a trend toward an increased frequency of spontaneous handling similar to genetic inhibition of CaMKII oxidation (which prevents activation).
Next, similar experiments were performed in myocytes paced at 3 Hz. After a 3-Hz pacing train, the incidence of spontaneous Ca 2+ waves was significantly higher in mdx mice (2.6±0.8 events/min) compared with WT littermates (0.6±0.4; P<0.05; Figure 4A and 4B Figure 4C ). In contrast, inhibition of ox-CaMKII in mdx mice normalized SR Ca 2+ content (4.2±0.4; P<0.05 versus mdx). Together, these data demonstrate that CaMKII oxidation is a key determinant of aberrant Ca 2+ homeostasis in myocytes from mdx mice.
Inhibition of Ox-CaMKII Prevents Triggered Activity in Isolated mdx Mouse Hearts
To gain more insight into the mechanisms underlying ventricular arrhythmias in mdx mice, optical mapping with simultaneous ECG monitoring was conducted ( Figure 5 ). Optical mapping of membrane potential was performed on perfused hearts ex vivo to visualize action potentials and epicardial activation sequences. In hearts from WT mice, sinus rhythm and normal epicardial activation patterns were observed. After atrial depolarization, ventricular epicardial activation started from the apex of the right ventricle and spread toward the base. These studies revealed that none of the 5 WT mice developed ventricular arrhythmias ( Figure 5A , 5B, and 5G). In contrast, 5 of 7 mdx mice (P<0.05 versus WT) exhibited ventricular arrhythmias, initiated by ectopic focal activity ( Figure 5A , 5C, 5D, and 5G). In one of these 5 mice, a clear rotor pattern could be seen following arrhythmia initiation. In the other 4 mice, arrhythmias seem to be caused by repeat focal activity. There was a trend toward a reduced ventricular arrhythmia incidence in mdx:MM-VV mice ( Figure 5G ; 1 of 6 mice; P=0.10 versus mdx). Next, we assessed the incidence of delayed afterdepolarizations (DADs) after a pacing train. WT mouse hearts did not exhibit any DADs (0 of 5 WT mice, Figure 5F and 5H ). In contrast, 5 of 7 mdx mouse hearts developed DAD (P<0.05; arrow in Figure 5F and 5H). There was a trend toward a reduction in DAD incidence in isolated mdx:MM-VV hearts (1 of 6 mdx:MM-VV; P=0.10; Figure 5F and 5H). KN-93, which is a small molecule inhibitor of CaMKII, also inhibited ventricular arrhythmia induction in mdx mice ( Figure III in the Data Supplement), confirming that CaMKII is a key factor responsible for ventricular arrhythmias in mdx mice.
NADPH Oxidase Mediates CaMKII Activation in mdx Mice
In a final set of experiments, we sought to determine whether NADPH oxidase is the source of ROS in mdx mice. 4 p47 phox is a key regulatory subunit of the NOX2 complex required for its activity. 17 The oxidation level of CaMKII was reduced in mdx:p47 −/− mice compared with mdx mice, suggesting that NOX2 mediates increased ox-CaMKII in mdx mice ( Figure 6A ). The incidence of inducible VT was also reduced in mdx:p47 −/− mice (0 of 8 mice) compared with mdx mice (10 of 20 mice; P<0.05; Figure 6B ). Finally, NOX2 inhibition by p47 phox ablation also reduced the frequency of Ca 2+ sparks frequency in mdx:p47 −/− mice (2.2±0.5 sparks/100 μm/s) compared with mdx (4.2±0.5, P<0.01; Figure 6C ). These results further support that NOX2-mediated oxidation of CaMKII is responsible for arrhythmogenic Ca 2+ release in mdx mice.
DISCUSSION
Enhanced CaMKII activity levels have been reported in several cardiovascular and pulmonary diseases, as well as cancer. 8, 18, 19 Because CaMKII is one of the key protein kinases that regulate intracellular Ca 2+ homeostasis in cardiac myocytes, altered CaMKII activity can facilitate the development of arrhythmias. Indeed, CaMKII hyperactivity has been associated with atrial fibrillation and ventricular arrhythmias in heart failure and dystrophic cardiomyopathy. 10, [20] [21] [22] CaMKII can be activated by several mechanisms, including an increased heart rate which leads to autophosphorylation of threonine 287 on neighboring CaMKII subunits within the holoenzyme complex, 23, 24 by ROS which leads to oxidation of methionine residues 281 and 282, 7 or by O-GlcNAcylation of serine 279. 25 In a prior study, we demonstrated that cardiac CaMKII autophosphorylation was not increased in 5-month-old mdx mice, whereas ox-CaMKII levels were increased. 10 Moreover, in the present study, we found that autonomous Ca
2+
/CaM-independent CaMKII activity was significantly increased in mdx mice (Figure 1) . Together, these findings suggest that ox-CaMKII is responsible for enhanced CaMKII enzymatic activity at least during early stages of dystrophic cardiomyopathy.
CaMKII can phosphorylate several Ca 2+ channels and transporters involved in excitation-contraction coupling, including both sarcolemmal and SR channels. In a previous study, we demonstrated that inhibition of CaMKII phosphorylation of RyR2 prevents ventricular arrhythmias and abnormal SR Ca 2+ leak in mdx mice. 10 KN-93 or the transgenic inhibitory peptide AC3I both suppressed CaMKII activity and reduced phosphorylation of S2814 on RyR2 in mdx mice. 10 RyR2 was proven to be a critical downstream target of CaMKII because mutation of the CaMKII phosphorylation site S2814 on RyR2 to alanine was sufficient to prevent the induction of ventricular arrhythmias in mdx mice. Similar to CaMKII posttranslational modifications, enhanced oxidation preceded increased phosphorylation of RyR2 in mdx mice as described before. 4 Other posttranslational modifications may contribute to enhanced RyR2-mediated SR Ca 2+ leak, including enhanced ROSdependent nitrosylation 26 and increased oxidation of RyR2. 5 This may promote a feed-forward mechanism by which enhanced RyR2 channel activity promotes increased ROS production and further protein oxidation. While direct RyR2 oxidation represents one possible mechanism contributing to mdx pathogenesis, our data show that CaMKII inhibition by KN-93 and oxidation site ablation (mdx:MM-VV; Figure 3 ) ameliorate aberrant SR Ca 2+ release. This demonstrates that targeting CaMKII activity is sufficient to normalize SR Ca 2+ in mdx mice. Another SR channel that can be affected by CaMKII phosphorylation is SERCA2a. CaMKII phosphorylation of phospholamban, a negative regulator of SERCA2a, derepresses SERCA2a activity. However, there is no evidence of enhanced SERCA2a activity in mdx mice. On the contrary, 2 prior publications showed reduced SERCA2a activity in mdx mice, 27, 28 whereas in our study, we did not find significant differences between SERCA2a activity comparing WT and mdx mice ( Figure I in the Data Supplement). One possible explanation for the discrepancy between our study and the previous studies is that we used mdx mice on a mixed Bl6/Bl10 background, whereas the previous studies were performed on mdx mice on a Bl10 background.
Sarcolemmal ion channels can also be phosphorylated by CaMKII. The L-type Ca 2+ channel, Na + channel, and NCX activity can be enhanced by CaMKII phosphorylation. However, in this study, we did not find a significant increase in NCX activity ( Figure I in the Data Supplement) and did not assess L-type Ca 2+ channel or Na + channel activity. The lack of change in NCX activity may be because of more pronounced ox-CaMKII activity near the SR as compared with the sarcolemma, at least in hearts of 5-month-old mdx mice.
In the present study, we found a 3-fold increase in the frequency of Ca 2+ sparks and spontaneous Ca 2+ waves, consistent with diastolic Ca 2+ leak through RyR2. 10 Diastolic release of Ca 2+ can cause DADs in myocytes from mdx mice, which in turn can lead to triggered ventricular arrhythmias ( Figure 5 ). In isolated hearts from mdx mice, we observed bidirectional VT and sustained VT, which are also seen in patients with catecholaminergic polymorphic ventricular tachycardia, a genetic condition caused by gain-of-function RyR2 mutations. 29 In addition, in some mdx mice, a re-entry pattern with rotor-like patterns was observed. These findings suggest that triggered arrhythmias may evolve into re-entrant arrhythmias, which may be facilitated by fibrotic structural remodeling 30 or temporary changes in Ca 2+ homeostasis as a result of the arrhythmia activity. 22 In this study, increased ROS production was detected in cardiomyocytes isolated from mdx mice, consistent with prior studies. 4, 31 Jung et al 31 suggested that enhanced fragility of the cell membrane resulting from the lack of dystrophin increases susceptibility to mechanical stress, which in turn causes more ROS production by membrane-associated NADPH. NOX2 and NOX4 are the most abundantly expressed isoforms in adult cardiomyocytes, and increased expression of both has been reported in hearts of mdx mice. 28, 32 Prosser et al 33 elegantly demonstrated that NOX2 is activated by disrupted membranes and mechanical stress. Enhanced stretch-dependent ROS production in mdx mice promotes intracellular Ca 2+ waves. 33 Our data are in agreement and show that ROS produced by NOX2 promotes SR Ca 2+ release abnormalities. Previously, we demonstrated increased ROS in mdx cardiomyocytes, which was abrogated by NOX2 inhibitor gp91ds. 4 Moreover, this is corroborated by the finding that p47 phox knockout reduced ox-CaMKII levels in mdx mice ( Figure 6 ). Taken together, these data suggest that in mdx mouse cardiomyocytes, increased NOX2-mediated ROS production increases ox-CaMKII, thereby promoting aberrant SR Ca 2+ release.
CONCLUSIONS
In this study, we demonstrated that mdx mice-a small animal model of DMD-are susceptible to pacinginduced ventricular arrhythmias. Ox-CaMKII promotes aberrant SR Ca 2+ release through RyR2, which leads to DADs and triggered ventricular arrhythmias. On the other hand, genetic inhibition of ox-CaMKII normalized intracellular Ca 2+ handling and prevented ventricular arrhythmias in mdx:MM-VV mice. Knockout of the NADPH oxidase regulatory subunit p47 phox normalized elevated ox-CaMKII levels, VT, and Ca 2+ homeostasis in mdx mice, suggesting that ox-CaMKII is increased by NADPH oxidase activity in mdx mice. Therefore, targeting this oxidation signaling pathway may represent a novel treatment strategy to prevent ventricular arrhythmias in DMD.
